[Is enoxaparine (PK 10169) a good anticoagulant in chronic hemodialysis?]. 1987

M E Briquel, and M Kessler, and E André, and T C Huu, and P Alexandre, and E Renoult, and B Jonon
Laboratoire d'Hémostase, C.R.T.S. de Nancy.

Tolerance and efficacy of single i. v. injections of PK 10169 (1 mg/kg) during installation were evaluated in 10 patients with stable chronic renal insufficiency treated with 3 sessions of hemodialysis weekly (sessions of 4 and 5 hours). Tolerance was good in all cases. Efficacy was globally satisfactory (no complete coagulation) but by the 4th hour in 7 out of 30 sessions coagulation was apparent in the bubble trap with elevation of residual blood volume, recurring in the same patient but not affecting result of dialysis. In these cases anti-Xa activity was reduced from the 2nd hour and at end of dialysis, with a markedly elevated FPA level. For most patients it is possible to envisage 5-hour sessions, but in those few susceptible to develop coagulation repeated clinical surveillance of all circuit elements is necessary.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001810 Blood Volume Volume of circulating BLOOD. It is the sum of the PLASMA VOLUME and ERYTHROCYTE VOLUME. Blood Volumes,Volume, Blood,Volumes, Blood
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006495 Heparin, Low-Molecular-Weight Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. LMWH,Low-Molecular-Weight Heparin,Low Molecular Weight Heparin,Heparin, Low Molecular Weight
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M E Briquel, and M Kessler, and E André, and T C Huu, and P Alexandre, and E Renoult, and B Jonon
January 1987, Journal des maladies vasculaires,
M E Briquel, and M Kessler, and E André, and T C Huu, and P Alexandre, and E Renoult, and B Jonon
January 1985, Annales pharmaceutiques francaises,
M E Briquel, and M Kessler, and E André, and T C Huu, and P Alexandre, and E Renoult, and B Jonon
January 1986, Haemostasis,
M E Briquel, and M Kessler, and E André, and T C Huu, and P Alexandre, and E Renoult, and B Jonon
January 1986, Haemostasis,
M E Briquel, and M Kessler, and E André, and T C Huu, and P Alexandre, and E Renoult, and B Jonon
October 1985, Thrombosis research,
M E Briquel, and M Kessler, and E André, and T C Huu, and P Alexandre, and E Renoult, and B Jonon
January 1986, Haemostasis,
M E Briquel, and M Kessler, and E André, and T C Huu, and P Alexandre, and E Renoult, and B Jonon
August 2006, Interactive cardiovascular and thoracic surgery,
M E Briquel, and M Kessler, and E André, and T C Huu, and P Alexandre, and E Renoult, and B Jonon
July 1985, Seminars in thrombosis and hemostasis,
M E Briquel, and M Kessler, and E André, and T C Huu, and P Alexandre, and E Renoult, and B Jonon
May 1985, Thrombosis research,
M E Briquel, and M Kessler, and E André, and T C Huu, and P Alexandre, and E Renoult, and B Jonon
January 1986, Haemostasis,
Copied contents to your clipboard!